`ÿÿ !ÿ"ÿ#$$%ÿ
`"!ÿ&ÿ'!%ÿ!( ÿ
` ÿÿ ÿ
`
`ÿÿ
`
`ÿÿ
`))))))))))))))))))))))ÿ
`+,ÿ-./ÿÿ01234ÿ+4567ÿ01234ÿ1048905:8;+42ÿ
`<+1+:3=7ÿ
`>??@AABCDEÿ
`))))))))))))))))))))))ÿ
`ÿFGHIJFHKHÿ
`))))))))))))))))))))))ÿ
`ÿ
`L
` Nÿ
`
`Rÿ
`MM
`ÿ ÿL
`ÿ ÿ ÿUQVFGHWJ
`GHXYFÿ
`))))))))))))))))))))))ÿ
`ÿZÿ;ÿ=ÿ3ÿ;ÿ
`ÿL
`ÿ M
`Nÿ
`ÿÿ
`
`
`O ÿ
` ÿ
`
`ÿU ÿUPÿVbVbÿ cL ÿ
`ÿdHeÿ
`
`ÿ ÿ
`
`
`
`
`ÿ
`ÿdFeÿf ÿgGÿ^ÿM
` Nÿ
`
`Sÿ
`
`
`ÿ Mÿ
`
`Rÿ
`MM
`
`Nÿÿ ]
`ÿ_
`ÿ
` ÿ
`a
`ÿÿÿ
`
`Amgen
`Exhibit 2067
`Apotex Inc., et al. v. Amgen Inc., et al.
`IPR2016-01542
`Ex. 2067-001
`
`
`
`Case:19-2171
`
`Document:9
`
`Page:2
`
`Filed: 08/15/2019
`
`2
`
`IN RE: AMGEN INC.
`
`August 15, 2019
`Date
`
`s29
`
`FOR THE COURT
`
`/s/ Peter R. Marksteiner
`Peter R. Marksteiner
`
`Clerk of Court
`
`(3) If the Director elects to participate as intervenor,
`his brief shall be served within 40 days of the date of filing
`of appellants’ opening brief.
`
`56789ÿ;<=>;?;ÿÿÿÿÿÿ@ABCD8EF9ÿ<ÿÿÿÿÿG6H89ÿ>ÿÿÿÿÿIJK8L9ÿMNO;PO>M;<
`ÿ
` ÿ ÿÿÿ
`ÿ
`ÿÿ
`
`ÿÿÿÿ ÿ!ÿ"#ÿ $ÿÿÿ ÿÿ%ÿ
`ÿ&ÿ%ÿ
`ÿÿ
`ÿÿÿÿÿÿÿÿÿÿÿ'( ÿ)*ÿ (+ )ÿ
`ÿ,%,ÿ-.ÿ#-/ÿÿÿÿÿÿÿ00ÿ1ÿ
`ÿ2ÿ
`ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ1ÿ
`ÿ2ÿ
`ÿÿÿÿÿÿÿÿÿÿÿ 2ÿÿ ,ÿÿÿÿÿÿ
`ÿ/ÿÿÿÿÿ+ ÿ3ÿ1ÿ ÿ) 42ÿ(ÿ
`
`cc: Director, United States Patent and Trademark Office
`
`Ex. 2067-002
`
`Ex. 2067-002
`
`